Stock ZS PHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News ZS Pharma Inc

Equities

US98979G1058

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for ZS Pharma Inc
2016 AstraZeneca : potassium drug delayed by manufacturing snag RE
2015 AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AstraZeneca : potassium drug delayed by manufacturing snag
RE
ZS Pharma : AstraZeneca completes acquisition of ZS Pharma
PU
AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug
RE
AbbVie : AstraZeneca buys most of Acerta for $4 billion to add cancer drug
RE
AbbVie : AstraZeneca chases Acerta to secure next cancer drug winner
RE
AstraZeneca : in talks to buy cancer drugmaker Acerta for $5 billion: WSJ
RE
ZS Pharma Announces New Employment Inducement Grants
GL
ZS Pharma : Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Shareholders To Contact The Firm For Additional Information
BU
ZS PHARMA : Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with AstraZeneca PLC
BU
ZS Pharma Announces New Employment Inducement Grants
GL
ZS Pharma : Brower Piven Commences An Investigation Into The Proposed Sale Of ZS Pharma, Inc. And Encourages Investors To Contact The Firm For Additional Information
BU
ZS Pharma Announces Positive Interim Results From a Long-Term Safety Study of ZS-9
GL
Wall St. flat as rate hike eyed; banks counter utilities drop
RE
Actelion : AstraZeneca buys ZS Pharma for $2.7 billion, pips Actelion
RE
Actelion : raises 2015 earnings forecast after strong drug sales
RE
ZS Pharma Announces Upcoming Poster Presentation of Interim Results From Its Long-Term Safety Study of ZS-9
GL
ZS Pharma Corporate Statement
GL
ZS Pharma Reports Second Quarter 2015 Financial Results and Provides Corporate Update
GL
ZS Pharma Announces FDA Acceptance of ZS-9 New Drug Application
GL
ZS Pharma Announces Participation at Upcoming Investor Conferences
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News ZS Pharma Inc